DIANA COLLINS: Open Payments
NPI 1053613646 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 64 payments from 18 companies in 2025. Trend: 2023 $1,303 · 2024 $1,067 · 2025 $1,333
Food & beverage: $1,294Education: $29Gift: $10
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 8 | $198 |
| ABBVIE INC. | 12 | $185 |
| Otsuka America Pharmaceutical, Inc. | 8 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Lundbeck LLC | 3 | $82 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $72 |
| Neos Therapeutics, LP | 4 | $67 |
| Alkermes, Inc. | 2 | $52 |
Products named: REXULTI, Azstarys, VRAYLAR, TRINTELLIX, CAPLYTA, Auvelity, Qelbree, ARISTADA.
Industry payments across TX — which companies pay providers there.
